Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

 

Autores
Perroud, Herman A; Scharovsky, O. Graciela; Rozados, Viviana R.; Alasino, Carlos María
Tipo de recurso
artículo
Estado
Versión publicada
Año de publicación
2017
País
Argentina
Institución
Universidad Nacional de Rosario
Repositorio
RepHipUNR (UNR)
Descripción
Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, doses of chemotherapeutic drugs with therapeutic efficacy and low toxicity. This is an effective and low-cost way to treat several types of tumours, including ovarian cancer. Here, we present six cases of advanced ovarian cancer treated with MCT with low doses of cyclophosphamide, which showed clinical response and stable disease.
Idioma
inglés
OAI Identifier
oai:rephip.unr.edu.ar:2133/11512
Enlace del recurso
http://hdl.handle.net/2133/11512
Nivel de acceso
Acceso abierto
Materia
ovarian cancer
metronomic chemotherapy
cyclophosphamide